Troponin-I ADV assay regulatory update

ABT submitted a 510(k) to FDA for the Troponin-I ADV test for use on the AxSYM automated immunoassay instrument system to diagnose heart attack. Troponin-I ADV will replace the existing AxSYM Troponin...